VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 224 filers reported holding VIR BIOTECHNOLOGY INC in Q2 2023. The put-call ratio across all filers is 1.94 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24,676 | -63.7% | 2,634 | -5.3% | 0.00% | – |
| Q2 2023 | $67,892 | +23.9% | 2,780 | +18.5% | 0.00% | – |
| Q1 2023 | $54,778 | -15.9% | 2,346 | -8.6% | 0.00% | – |
| Q4 2022 | $65,164 | -10.7% | 2,566 | -31.7% | 0.00% | – |
| Q3 2022 | $73,000 | +128.1% | 3,758 | +198.7% | 0.00% | – |
| Q2 2022 | $32,000 | -87.8% | 1,258 | -84.5% | 0.00% | -100.0% |
| Q1 2022 | $262,000 | -34.0% | 8,106 | -17.5% | 0.00% | 0.0% |
| Q4 2021 | $397,000 | +15.7% | 9,826 | +9.4% | 0.00% | 0.0% |
| Q3 2021 | $343,000 | +3.9% | 8,980 | +20.8% | 0.00% | 0.0% |
| Q2 2021 | $330,000 | -11.1% | 7,431 | +0.3% | 0.00% | 0.0% |
| Q1 2021 | $371,000 | -29.1% | 7,409 | -62.0% | 0.00% | 0.0% |
| Q4 2020 | $523,000 | +868.5% | 19,510 | +1160.3% | 0.00% | – |
| Q3 2020 | $54,000 | -53.8% | 1,548 | -46.1% | 0.00% | – |
| Q2 2020 | $117,000 | +21.9% | 2,870 | +2.5% | 0.00% | – |
| Q1 2020 | $96,000 | – | 2,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $30,100,000 | 23.79% |
| SB INVESTMENT ADVISERS (UK) LTD | 22,086,280 | $425,823,000 | 3.26% |
| Zebra Capital Management LLC | 40,104 | $773,000 | 2.94% |
| UNIVERSITY OF TEXAS/TEXAS AM INVESTMENT MANAGEMENT CO | 130,409 | $2,514,000 | 0.94% |
| CLARK ESTATES INC/NY | 180,000 | $3,470,000 | 0.77% |
| Temasek Holdings (Private) Ltd | 6,036,821 | $116,389,909 | 0.70% |
| SECTOR GAMMA AS | 89,808 | $1,731,000 | 0.45% |
| Capital Impact Advisors, LLC | 13,196 | $360,000 | 0.36% |
| SummerHaven Investment Management, LLC | 24,927 | $481,000 | 0.33% |
| DUALITY ADVISERS, LP | 92,712 | $1,787,000 | 0.20% |